HEA (human erythrocyte antigen) and HPA (human platelet antigen) testing allows simultaneous testing for multiple antigens in one assay. Higher resolution testing, including genomic and cDNA sequence analysis is used to characterize variant antigens and resolve typing discrepancies.

HEA panel that allows for best matched red cell blood product for the patient and the avoidance of alloimmunization.

PreciseType TM HEA provides doctors with highly detailed, genetic information about blood so they can make better matches between donors and recipients. Information from this test helps prevent mismatches that can cause potentially life-threatening reactions.

PreciseType TM HEA test provides clinicians with an exceptional new tool to assist in determining donor-patient compatibility. In a multi-site, multi-operator study assessing reproducibility and repeatability using a fully characterized panel of 11 human genomic DNA samples tested over five (5) days, PreciseType TM results were 100% repeatable ...

Is an in vitro diagnostic test intended for the molecular determination of allelic variants that predict erythrocyte antigen phenotypes

The Invitae Hereditary Angioedema Panel analyzes genes that are associated with hereditary angioedema. Angioedema is characterized by recurrent episodes of swelling of the subcutaneous or mucosal tissues of the respiratory and intestinal tracts, limbs, and face.

The human erythrocyte antigen, HEA BeadChip ™ Test Kit is an in-vitro diagnostic test and multiplexed molecular assay that generates detailed molecular information from patient and donor samples, rapidly detecting genotypes for accurate prediction of phenotypes:

Blood Draw Hours of Operation. Clinical Updates. Certifications and Accreditations. Requisitions.

Maccaferri HEA Panels (High Energy Absorption) are the stiffest products within our Mac.RO (TM) Systems mesh range, offering extreme strength at low strain. Stiffness is more important than tensile strength of meshes as it affects the deflection of the system under load.

Aid clinicians in obtaining an appropriate diagnosis of hereditary angioedema (HAE). The profile begins with complement C 4 and complement C 1 esterase inhibitor with reflexing, if required, to complement C 1 esterase inhibitor, functional to distinguish HAE type I from type II.